Search company, investor...
Geminus Therapeutics company logo

Geminus Therapeutics

Founded Year



Grant | Alive

Total Raised


Last Raised

$150K | 2 yrs ago

About Geminus Therapeutics

Geminus Therapeutics operates as a drug delivery company. It develops artemisinin (ART714) for treating leukemia. The company was founded in 2020 and is based in Baltimore, Maryland.

Headquarters Location

1100 Wicomico Street Suite 323

Baltimore, Maryland, 21230,

United States



Geminus Therapeutics Frequently Asked Questions (FAQ)

  • When was Geminus Therapeutics founded?

    Geminus Therapeutics was founded in 2020.

  • Where is Geminus Therapeutics's headquarters?

    Geminus Therapeutics's headquarters is located at 1100 Wicomico Street, Baltimore.

  • What is Geminus Therapeutics's latest funding round?

    Geminus Therapeutics's latest funding round is Grant.

  • How much did Geminus Therapeutics raise?

    Geminus Therapeutics raised a total of $150K.

  • Who are the investors of Geminus Therapeutics?

    Investors of Geminus Therapeutics include Maryland Technology Development Corporation and University of Maryland.



CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.